Combined Chemotherapy for Recurrent and Metastatic Nasopharyngeal Carcinoma

References

• Ho JHC. An epidemiologic and clinical study of naso pharyngeal carcinoma. J Radiat Oncol Biol Phys 1978; 4: 183–198.
   Google Scholar
• Micheau C, de The G, Orofiamma B. Practical value of classifying NPC in two major microscopical types. In: Grundmann E., Krueger G.R.F., Ablashi D.V., (eds), Cancer Campaign, Vol. 5, New York: Gustave Fischer, 1981: 51–57.
   Google Scholar
• Wang CC, Meyer JE. Radiotherapeutic management of carcinoma of the nasopharynx. Cancer 1971; 28: 566–571.
   Google Scholar
• Zucali R, Milani F. Storia naturale dei carcinomi della rinofaringe. In: I tumori della testa e del collo. Veronesi U., Bocca E., Molinari R. (eds). Emanuelli H., Ambrosiana – Milano, 1979: 243–254.
   Google Scholar
• Mesic JB, Fletcher GH, Goepfert H. Megavoltage irradiation of epithelial tumours of the nasopharynx. Int J Radiat Oncol Biol Phys 1981; 7: 447–453.
   Google Scholar
• Papac R. Distant metastases from head and neck cancer. Cancer 1984; 53: 342–345.
   Google Scholar
• Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results in cancer treatment. Cancer 1981; 47: 207–214.
   Google Scholar
• Airoldi M, Fazio M, Gandolfo S. et al. Combined cryosurgical, chemotherapeutic, and radiotherapeutic management of T1–4NOMO oral cavity cancers. Cancer 1985; 56: 424–431.
   Google Scholar
• Airoldi M, Pedani F, Brando V, Giordano C, Gabriele P. Cisplatin and 5-Fluorouracil in recurrent head and neck cancer: results of an outpatient schedule. Chemioterapia 1988; 7: 127–129.
   Google Scholar
• Airoldi M, Pedani F, Gabriele P, Giordano C, Pia F. Vincristina-Bleomicina-Methotrexate nel trattamento delle recidive dei carcinomi ORL. Acta Otorhinol 1988; 8: 125–131.
   Google Scholar
• Brando V, Airoldi M, Pedani F, Gabriele P, Orecchia R. Cisplatino, epirubicina, ciclofosfamide (PEC) nelle recidive del carcinoma indifferenziato della rinofaringe. Tumori 1987; 73 (4): 142.
   Google Scholar
• Al-Kourainy K, Crissman J, Ensely J, Kish J, Reed M, Kelly D, Al-Sarraf M. Excellent response to cis-platinum based combination for recurrent and previously untreated locally advanced nasopharyngeal carcinoma. (Abstr.) Proc Am Soc Clin Oncol 1985; 4: 131.
   Google Scholar
• Choksi A, Dimery I, Hong W, et al. Sequential induction chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma. (Abstr.) Proc Am Soc Clin Oncol 1988; 7: 151.
   Google Scholar
• Hill BT, Price LA, MacRae K. Importance of primary site in assessing chemotherapy response and 7-year survival data in advanced squamous-cell carcinomas of the head and neck treated with initial combination chemotherapy without cisplatin. J Clin Oncol 1986; 4: 1340–1347.
   Google Scholar
• Lai GM, Ng KT. High dose 5-Fluorouracil plus cisplatinum in treatment of advanced nasopharyngeal carcinoma. (Abstr.) Proc Am Soc Clin Oncol 1986; 5: 143.
   Google Scholar
• Tannock I, Payne D, Cummings B, Hewitt K, Panzarella T. Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a high rate of tumor response to chemotherapy. J Clin Oncol 1987; 5: 629–634.
   Google Scholar
• Weichselbaum RR, Clark JR, Miller D, Posner MR, Ervin TJ. Combined modality treatment of head and neck cancer with cisplatin, bleomycin, methotrexate-leucovorin chemotherapy. Cancer 1985; 55: 2149–2155.
   Google Scholar
• Zidan J, Kuten A, Cohen Y, Robinson E. Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin combined with radical radiotherapy in advanced head and neck cancer. Cancer 1987; 59: 24–26.
   Google Scholar
• Richards GJ, Chambers RG. Hydroxyurea in the treatment of neoplasms of the head and neck. A resurvey. Am J Surg 1973; 126: 513–518.
   Google Scholar
• Huang SC, Lui LT, Lynn TC. Nasopharyngeal cancer: study III. A review of 1206 patients treated with combined modalities. Int J Radiat Oncol Biol Phys 1985; 11: 1789–1793.
   Google Scholar
• Al-Sarraf M, Zundmanis M, Marcial V, Laramore G. Current cis-platinum and radiotherapy in patients with locally advanced nasopharyngeal carcinomas. (Abstr.) Proc Am Soc Clin Oncol 1986; 5: 142.
   Google Scholar
• O’Connor D, Clifford P, Edwards WG, Dalley VM, Durdensmith J, Hollis BA, Caiman FM. Long-term results of VBM and radiotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1982: 8: 1525–1531.
   Google Scholar
• Armand JP, Rahal M, Azli N, et al. Alternating chemoradiotherapy in undifferentiated carcinoma nasopharyngeal type with advanced (N3) nodal disease. (Abstr.) Proc Am Soc Clin Oncol 1988; 7: 151.
   Google Scholar
• Dimery IW, Legha SS, Peters LJ, Goepfert H, Oswald MJ. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma. Cancer 1987; 60: 943–949.
   Google Scholar
• Rahima M, Rakowsky E, Barzilay J, Sidi J. Carcinoma of the nasopharynx. An analysis of 91 cases and a comparison of differing treatment approaches. Cancer 1986; 58: 843–849.
   Google Scholar
• Rossi A, Molinari R, Marubini E, et al. Adjuvant chemotherapy after complete response to radiotherapy in na sopharyngeal cancer: follow-up of a randomized study. (Abstr.) Proc Am Soc Clin Oncol 1986; 5: 147.
   Google Scholar
• Molinari R, Cantù G, Costa L, Mattavelli F, Beretta G. Prospettive per un trattamento multidisciplinare dei carcinomi del rinofaringe. In: I tumori della testa e del collo. Veronesi U., Bocca E., Molinari R., Emanuelli H. (eds). Ambrosiana – Milano, 1979: 265–271.
   Google Scholar
• Goldsmith MA, Carter SK. The integration of che motherapy into a combined modality approach to cancer therapy. V: Squamous cell cancer of the head and neck. Cancer Treat Rev 1975; 2: 137–158.
   Google Scholar
• Bertino JR, Boston B, Capizzi RL. The role of chemotherapy in the management of cancer of the head and neck: a review. Cancer 1975; 36: 752–758.
   Google Scholar
• Decker DA, Drelichman A, Al-Sarraf M, Crissman J, Reed ML. Chemotherapy for nasopharyngeal carcinoma. A ten-year experience. Cancer 1983; 52: 602–605.
   Google Scholar
• Richman SP, Livingston RB, Gutterman JU, Suen JY, Hersh EM. Chemotherapy versus chemoimmunotherapy of head and neck cancer: report of a randomized study. Cancer Treat Rep 1976; 60: 535–539.
   Google Scholar
• Cortes EP, Kalra J, Amin VC. Chemotherapy for head and neck relapsing after radiotherapy. Cancer 1981; 47: 1966–1970.
   Google Scholar
• Panasci L, Gravenor D, Black M, Frenkiel S, Margolese R. Alternating combination chemotherapy using cisplatinbleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer. Cancer Treat Rep 1985; 69: 1015–1017.
   Google Scholar
• Cvitkovic E, Boussen H, Azli N, et al. Increased complete response percentage with BEC (bleomycin, epirubicin, cisplatinum) in metastatic/advanced undifferentiated carcinoma nasopharyngeal type. (Abstr.). Proc Am Soc Clin Oncol 1988; 7: 155.
   Google Scholar